Welcome to our dedicated page for Christina Lake C news (Ticker: CLCFF), a resource for investors and traders seeking the latest updates and insights on Christina Lake C stock.
Christina Lake Cannabis reports developments tied to its licensed Canadian cannabis cultivation, processing, and research operations. The company produces outdoor flower, extracts, and distillate for a B2B client base and operates cultivation and processing assets in British Columbia, including outdoor grow space, propagation and drying rooms, research facilities, greenhouses, and extraction infrastructure.
Recurring news covers financial-statement filings and related management cease trade order updates, operating performance, product mix, cultivation capacity, and supply-chain expansion following the Midway acquisition. Company announcements also address financing arrangements, equipment leases, asset dispositions involving non-core land, working-capital needs, and Health Canada licensing for standard cultivation, processing, and research and development activities.
Summary not available.
Summary not available.
Summary not available.
Christina Lake Cannabis Corp. (CSE: CLC, OTCQB: CLCFF) announced significant corporate updates, including a 75% increase in distillate production capacity. The 2022 crop also yielded a 20% increase in THC extraction per kg of biomass. Preparations for the 2023 crop are ahead of schedule, with enhancements to greenhouses leading to early starts. The first shipment of medical oils to South Africa is expected in fiscal Q3 2023, along with new customized formulation capabilities. CLC is diversifying its product line to include pre-rolls, infused pre-rolls, kief, and hash. The company aims to leverage its technology and expertise to drive revenue growth and enhance shareholder value amid competitive market conditions.
Christina Lake Cannabis Corp. (CSE: CLC, OTCQB: CLCFF) reported a remarkable 177% increase in revenue, reaching $10.1M for fiscal 2022, up from $3.6M in the prior year.
Despite revenue growth, the gross margin decreased to 41.1% compared to 60.6% in fiscal 2021. The company reduced its G&A expenses by 14% or $729k, enhancing profitability.
An inventory write-down of $2.47M was reported, less than the $3.86M from the previous year. The company realized a net loss of $2.0M, improving from $7.1M in fiscal 2021.
Christina Lake Cannabis Corp. has signed a Supply Agreement with Africann Group to deliver custom medicinal cannabis oils to South Africa. This partnership is a key milestone in Christina Lake's strategy for revenue growth and product diversification. CEO Mark Aiken emphasized the company's focus on leveraging technology and formulation expertise to create value-added products. Africann's CCO, Craig Ludwig, highlighted that the collaboration will enable the provision of high-quality, cost-effective cannabis medicines to South African patients. Christina Lake Cannabis operates a large facility for producing cannabis extracts and holds necessary licenses under Canadian law.
Christina Lake Cannabis Corp. (CSE: CLC) (OTCQB: CLCFF) announced a successful 2022 harvest with approximately 42,000 kg of dried biomass, an 11% increase from 2021. Initial potency tests indicate a significant rise in THC levels, attributed to improved strain selection and genetics. The company has also acquired new processing equipment to boost production throughput and resolve previous constraints, enhancing their product variety and inventory monetization. CEO Mark Aiken highlighted these achievements as pivotal for customer offerings and financial performance.
On December 9, 2022, Christina Lake Cannabis Corp. announced significant management changes including Jay McMillan as the new Chairman of the Board, transitioning from Mervin Boychuk, who will remain as a Director. Rob Jones, the President, is retiring. Milan Stefancik has been promoted to Vice President of Sales and Marketing. McMillan brings extensive cannabis industry experience, including key roles at HEXO Corp. The Company aims to enhance its market position and product diversification under new leadership.
Christina Lake Cannabis Corp. (CSE: CLC) reported strong financial results for Q3 2022, with total sales increasing by 25% quarter-over-quarter and 126% year-over-year, reaching $2.9M. The gross margin before fair value adjustments stood at 48%. General and administrative expenses dropped to 35% of revenue, down from 42% in Q2 2022 and 100% in Q3 2021. Net income for the quarter was $2.5M, reflecting a decrease from the prior year, mainly due to changes in biological asset valuations. The company maintains a strong working capital of $10.4M.
Christina Lake Cannabis Corp. (CSE: CLC, OTCQB: CLCFF) is on track for its third cultivation season with a promising crop of THC-rich cannabis. The company aims to enhance its oil extraction processes by leveraging advanced genetics and cultivation techniques. In 2022, CLC plans to harvest 41 strains, utilizing advanced drone technology for monitoring. Additionally, it amended the terms of $62,000 in convertible debentures to extend maturity and preserve capital for operations. The upcoming harvest is projected to last 6-7 weeks, starting in September 2022.